Literatur

1. Gloy K. Aristoteles`Konzeption der Seele in "de anima". Zeitschrift für Philosophische Forschung. 1984: 381-412.

2. Harvey W. On The Motion Of The Heart And Blood InAnimals; 1628.

3. Committe. A definition of irreversible coma. Report of the Ad Hoc Committee of the Harvard Medical School to Examine the Definition of Brain Death. Jama. 1968; 205: 337-40.

4. Le Gallois J. Expériences sur le principe de la vie, notamment sur celui des mouvemens du coeur, et sur le siège de se principe; Suivies du rapport fait à la prem`ère classe de lÌnstitut sur celles relatives aux mouvemens du coeur. Paris: D`Hautel. 1812: 134-135.

5. Reidemeister J. Die Entwicklung der extrakorporalen Zirkulation und der heutige Stand ihrer Anwendungsmöglichkeiten. Chirurg. 1971; 12: 202-208.

6. Loebell C. De conditionibus quibus secretiones in glandulis perficiuntur. Dissertatio Inauguralis Marburg. 1849.

7. Schmidt A. Die Athmung innerhalb des Blutes. Zweite Abhandlung. – Aus dem physiologischen Institute zu Leipzig. Vorgelegt von dem wirkl. Mitgliede C. Ludwig. Berichte über die Verhandlungen der königlich sächsischen Gesellschaft der Wissenschaften zu Leipzig. Matthematisch-physische Classe. 1867: 99-130.

8. von Schröder W. Über die Bildungsstätte des Harnstoffs. Archiv für experimentelle Pathologie und Pharmakologie. 1882: 364-400.

9. von Frey MG, M. Untersuchungen über den Stoffwechsel isolierter Organe. Ein Respirationsapparat für isolierte Organe. Archiv für Anatomie und Physiologie. Physiologische Abtheilung. Leipzig. 1885: 519-532.

10. Jacobi C. Apparat zur Durchblutung isolierter überlebender Organe. Archiv für experimentelle Pathologie und Pharmakologie (Naunyn/Schmiedeberg). 1890: 388-397.

11. Gibbon J, Jr. Application of a mechanical heart and lung apparatus to cardiac surgery. Minnesota Medicine. 1954: 171-187.


[Seite 57↓]

12. Böttcher W. Die historische Entwicklung der extrakorporalen Zirkulation. In: Lauterbach G, ed. Handbuch der Kardiotechnik. 4 ed. München, Jena: Urban und Fischer; 2002: 1-24.

13. Zeller O. Versuche zur Wiederbelebung von Tieren mittels arterieller Durchströmung des Herzens und der nervösen Zentralorgane. Deutsche Zeitschrift für Chirurgie. 1908: 488-559.

14. Gibbon Jj. Application of a medical heart and lung apparatus to cardiac surgery. Minnesota Medicine. 1954: 171-180.

15. Lillehei CW, Varco RL, Cohen M, Warden HE, Patton C, Moller JH. The first open-heart repairs of ventricular septal defect, atrioventricular communis, and tetralogy of Fallot using extracorporeal circulation by cross-circulation: a 30-year follow-up. Ann Thorac Surg. 1986; 41: 4-21.

16. DeBakey ME. The odyssey of the artificial heart. Artif Organs. 2000; 24: 405-11.

17. Barnard CN. The operation. A human cardiac transplant: an interim report of a successful operation performed at Groote Schuur Hospital, Cape Town. S Afr Med J. 1967; 41: 1271-4.

18. Bartlett RH, Gazzaniga AB, Jefferies MR, Huxtable RF, Haiduc NJ, Fong SW. Extracorporeal membrane oxygenation (ECMO) cardiopulmonary support in infancy. Trans Am Soc Artif Intern Organs. 1976; 22: 80-93.

19. DeVries WC, Anderson JL, Joyce LD, Anderson FL, Hammond EH, Jarvik RK, Kolff WJ. Clinical use of the total artificial heart. N Engl J Med. 1984; 310: 273-8.

20. Palenker J, Lusebrink R, Kaiser M, John TA, Slama K, Baer P, Frank J, Zartnack F, Hennig E, Bucherl ES. Temporary implantation of the Berlin artificial heart system. Int J Artif Organs. 1987; 10: 263-8.

21. Ishino K, Loebe M, Uhlemann F, Weng Y, Hennig E, Hetzer R. Circulatory support with paracorporeal pneumatic ventricular assist device (VAD) in infants and children. Eur J Cardiothorac Surg. 1997; 11: 965-72.

22. Nose Y. FDA approval of clinical studies on left ventricular assist system for its therapeutic application. Artif Organs. 1996; 20: 283.

23. SoRelle R. Third abiocor artificial heart implanted in Houston. Circulation. 2001; 104: E9033-4.


[Seite 58↓]

24. Morrow WR, Frazier E, Naftel DC. Survival after listing for cardiac transplantation in children. 2000; 11: 99-105.

25. Hetzer R, Loebe M, Potapov EV, Weng Y, Stiller B, Hennig E, Alexi-Meskishvili V, Lange PE. Circulatory support with pneumatic paracorporeal ventricular assist device in infants and children. Ann Thorac Surg. 1998; 66: 1498-506.

26. Mehta U, Laks H, Sadeghi A, Marelli D, Odim J, Alejos J, Kim M, Atkinson JB, Bui KC. Extracorporeal membrane oxygenation for cardiac support in pediatric patients. Am Surg. 2000; 66: 879-86.

27. Muehrcke DD, McCarthy PM, Stewart RW, Seshagiri S, Ogella DA, Foster RC, Cosgrove DM. Complications of extracorporeal life support systems using heparin-bound surfaces. The risk of intracardiac clot formation. J Thorac Cardiovasc Surg. 1995; 110: 843-51.

28. Bocsi J, Hambsch J, Osmancik P, Schneider P, Valet G, Tarnok A. Preoperative prediction of pediatric patients with effusions and edema following cardiopulmonary bypass surgery by serological and routine laboratory data. Crit Care. 2002; 6: 226-33.

29. Tarnok A, Hambsch J, Emmrich F, Sack U, van Son J, Bellinghausen W, Borte M, Schneider P. Complement activation, cytokines, and adhesion molecules in children undergoing cardiac surgery with or without cardiopulmonary bypass. Pediatr Cardiol. 1999; 20: 113-25.

30. Bartlett RH, Gazzaniga AB, Fong SW, Jefferies MR, Roohk HV, Haiduc N. Extracorporeal membrane oxygenator support for cardiopulmonary failure. Experience in 28 cases. J Thorac Cardiovasc Surg. 1977; 73: 375-86.

31. Kim ES, Stolar CJ. ECMO in the newborn. Am J Perinatol. 2000; 17: 345-56.

32. Tenderich G, Koerner MM, Stuettgen B, Minami K, El-Banayosy A, Arusoglu L, Mirow N, Wlost S, Gromzik H, Kleesiek K, Meyer H, Koerfer R. Mechanical circulatory support after orthotopic heart transplantation. Int J Artif Organs. 1998; 21: 414-6.

33. Kirshbom PM, Bridges ND, Myung RJ, Gaynor JW, Clark BJ, Spray TL. Use of extracorporeal membrane oxygenation in pediatric thoracic organ transplantation. J Thorac Cardiovasc Surg. 2002; 123: 130-6.


[Seite 59↓]

34. Darling EM, Kaemmer D, Lawson DS, Jaggers JJ, Ungerleider RM. Use of ECMO without the oxygenator to provide ventricular support after Norwood Stage I procedures. Ann Thorac Surg. 2001; 71: 735-6.

35. Jaggers JJ, Forbess JM, Shah AS, Meliones JN, Kirshbom PM, Miller CE, Ungerleider RM. Extracorporeal membrane oxygenation for infant postcardiotomy support: significance of shunt management. Ann Thorac Surg. 2000; 69: 1476-83.

36. Aharon AS, Drinkwater DC, Jr., Churchwell KB, Quisling SV, Reddy VS, Taylor M, Hix S, Christian KG, Pietsch JB, Deshpande JK, Kambam J, Graham TP, Chang PA. Extracorporeal membrane oxygenation in children after repair of congenital cardiac lesions. Ann Thorac Surg. 2001; 72: 2095-101; discussion 2101-2.

37. Matsuda H, Taenaka Y, Ohkubo N, Ohtani M, Nishigaki K, Ohtake S, Miura T, Taenaka N, Takano H, Hirose H, et al. Use of a paracorporeal pneumatic ventricular assist device for postoperative cardiogenic shock in two children with complex cardiac lesions. Artif Organs. 1988; 12: 423-30.

38. Taenaka Y, Takano H, Nakatani T, Umezu M, Tanaka T, Akutsu T, Naito Y, Manabe H. Ventricular assist device (VAD) for children: in vitro and in vivo evaluation. Trans Am Soc Artif Intern Organs. 1984; 30: 155-8.

39. Warnecke H, Berdjis F, Hennig E, Lange P, Schmitt D, Hummel M, Hetzer R. Mechanical left ventricular support as a bridge to cardiac transplantation in childhood. Eur J Cardiothorac Surg. 1991; 5: 330-3.

40. Bachmann C, Hugo G, Rosenberg G, Deutsch S, Fontaine A, Tarbell JM. Fluid dynamics of a pediatric ventricular assist device. Artif Organs. 2000; 24: 362-72.

41. Konertz W. Mechanical circulatory assist in pediatric patients. Int J Artif Organs. 1997; 20: 681-3.

42. Hawkins J. Intra-aortic balloon counterpulsation for children with cardiac surgery. In: Duncan B, ed. Mechanical Support for Cardiac and respiratory failure in pediatric patients. New York, Basel: Marcel Dekker, Inc.; 2001: 49-60.

43. Akomea-Agyin C, Kejriwal NK, Franks R, Booker PD, Pozzi M. Intraaortic balloon pumping in children. Ann Thorac Surg. 1999; 67: 1415-20.


[Seite 60↓]

44. Pinkney KA, Minich LL, Tani LY, Di R, Veasy LG, McGough EC, Hawkins JA. Current results with intraaortic balloon pumping in infants and children. Ann Thorac Surg. 2002; 73: 887-91.

45. Ramasamy NV, RL; Kormos, RL; Portner, PM; The Novacor left ventricular assist system. In: Goldstein DO, M, ed. Cardiac assist device. Armonk, New York: Futura; 2000: 323-39.

46. Goldstein DO, M. Intracorporeal support: Thermo cardiosystems ventricular assist devices. In: Goldstein DO, M, ed. Cardiac assist devices. Amonk, New York: Futura; 2000: 307-22.

47. Reinhartz O, Keith FM, El-Banayosy A, McBride LR, Robbins RC, Copeland JG, Farrar DJ. Multicenter experience with the thoratec ventricular assist device in children and adolescents. J Heart Lung Transplant. 2001; 20: 439-48.

48. Reinhartz O, Stiller B, Eilers R, Farrar DJ. Current clinical status of pulsatile pediatric circulatory support. Asaio J. 2002; 48: 455-9.

49. DeBakey ME. A miniature implantable axial flow ventricular assist device. Ann Thorac Surg. 1999; 68: 637-40.

50. Noon GP, Morley DL, Irwin S, Abdelsayed SV, Benkowski RJ, Lynch BE. Clinical experience with the MicroMed DeBakey ventricular assist device. Ann Thorac Surg. 2001; 71: S133-8; discussion S144-6.

51. Westaby S, Frazier OH, Beyersdorf F, Saito S, Siegenthaler MP, Pigott DW, Catarino PA, Jarvik R. The Jarvik 2000 Heart. Clinical validation of the intraventricular position. Eur J Cardiothorac Surg. 2002; 22: 228-32.

52. Frazier OH, Myers TJ, Gregoric ID, Khan T, Delgado R, Croitoru M, Miller K, Jarvik R, Westaby S. Initial clinical experience with the Jarvik 2000 implantable axial-flow left ventricular assist system. Circulation. 2002; 105: 2855-60.

53. Frazier OH, Myers TJ, Jarvik RK, Westaby S, Pigott DW, Gregoric ID, Khan T, Tamez DW, Conger JL, Macris MP. Research and development of an implantable, axial-flow left ventricular assist device: the Jarvik 2000 Heart. Ann Thorac Surg. 2001; 71: S125-32; discussion S144-6.

54. Westaby S, Banning AP, Jarvik R, Frazier OH, Pigott DW, Jin XY, Catarino PA, Saito S, Robson D, Freeland A, Myers TJ, Poole-Wilson PA. First permanent implant of the Jarvik 2000 Heart. Lancet. 2000; 356: 900-3.


[Seite 61↓]

55. Griffith BP, Kormos RL, Borovetz HS, Litwak K, Antaki JF, Poirier VL, Butler KC. HeartMate II left ventricular assist system: from concept to first clinical use. Ann Thorac Surg. 2001; 71: S116-20; discussion S114-6.

56. Schmitz-Rode T, Pfeffer JG, Graf S, Buss F, Brucker C, Siess T, Gunther RW. Axial flow catheter pump for circulatory support. Biomed Tech (Berl). 2002; 47 Suppl 1 Pt 1: 142-3.

57. Siess T, Nix C, Menzler F. From a lab type to a product: a retrospective view on Impella's assist technology. Artif Organs. 2001; 25: 414-21.

58. Dowling RD, Etoch SW, Stevens KA, Johnson AC, Gray LA, Jr. Current status of the AbioCor implantable replacement heart. Ann Thorac Surg. 2001; 71: S147-9; discussion S183-4.

59. Mehta SM, Pae WE, Jr., Rosenberg G, Snyder AJ, Weiss WJ, Lewis JP, Frank DJ, Thompson JJ, Pierce WS. The LionHeart LVD-2000: a completely implanted left ventricular assist device for chronic circulatory support. Ann Thorac Surg. 2001; 71: S156-61; discussion S183-4.

60. Stiller B, Dahnert I, Weng YG, Hennig E, Hetzer R, Lange PE. Children may survive severe myocarditis with prolonged use of biventricular assist devices. Heart. 1999; 82: 237-40.

61. del Nido PJ, Dalton HJ, Thompson AE, Siewers RD. Extracorporeal membrane oxygenator rescue in children during cardiac arrest after cardiac surgery. Circulation. 1992; 86: II300-4.

62. Grundl PD, Miller SA, del Nido PJ, Beerman LB, Fuhrman BP. Successful treatment of acute myocarditis using extracorporeal membrane oxygenation. Crit Care Med. 1993; 21: 302-4.

63. Dalton HJ, Siewers RD, Fuhrman BP, Del Nido P, Thompson AE, Shaver MG, Dowhy M. Extracorporeal membrane oxygenation for cardiac rescue in children with severe myocardial dysfunction. Crit Care Med. 1993; 21: 1020-8.

64. del Nido PJ, Armitage JM, Fricker FJ, Shaver M, Cipriani L, Dayal G, Park SC, Siewers RD. Extracorporeal membrane oxygenation support as a bridge to pediatric heart transplantation. Circulation. 1994; 90: II66-9.


[Seite 62↓]

65. del Nido PJ, Duncan BW, Mayer JE, Jr., Wessel DL, LaPierre RA, Jonas RA. Left ventricular assist device improves survival in children with left ventricular dysfunction after repair of anomalous origin of the left coronary artery from the pulmonary artery. Ann Thorac Surg. 1999; 67: 169-72.

66. Manolio TA, Baughman KL, Rodeheffer R, Pearson TA, Bristow JD, Michels VV, Abelmann WH, Harlan WR. Prevalence and etiology of idiopathic dilated cardiomyopathy (summary of a National Heart, Lung, and Blood Institute workshop. Am J Cardiol. 1992; 69: 1458-66.

67. Matitiau A, Perez-Atayde A, Sanders SP, Sluysmans T, Parness IA, Spevak PJ, Colan SD. Infantile dilated cardiomyopathy. Relation of outcome to left ventricular mechanics, hemodynamics, and histology at the time of presentation. Circulation. 1994; 90: 1310-8.

68. Chang AC, Hanley FL, Weindling SN, Wernovsky G, Wessel DL. Left heart support with a ventricular assist device in an infant with acute myocarditis. Crit Care Med. 1992; 20: 712-5.

69. Duncan BW, Bohn DJ, Atz AM, French JW, Laussen PC, Wessel DL. Mechanical circulatory support for the treatment of children with acute fulminant myocarditis. J Thorac Cardiovasc Surg. 2001; 122: 440-8.

70. Duncan BW, Hraska V, Jonas RA, Wessel DL, Del Nido PJ, Laussen PC, Mayer JE, Lapierre RA, Wilson JM. Mechanical circulatory support in children with cardiac disease. J Thorac Cardiovasc Surg. 1999; 117: 529-42.

71. Duncan BW. Mechanical circulatory support for infants and children with cardiac disease. Ann Thorac Surg. 2002; 73: 1670-7.

72. Patel NC, Jothi M, Trivedi DB, Sabino G, Daly P, Booker PD, Pozzi M. Post-cardiotomy mechanical circulatory support using a conventional bypass circuit in children. Eur J Cardiothorac Surg. 2001; 20: 811-5.

73. Long JW. Advanced mechanical circulatory support with the HeartMate left ventricular assist device in the year 2000. Ann Thorac Surg. 2001; 71: S176-82; discussion S183-4.

74. Scheinin SA, Radovancevic B, Parnis SM, Ott DA, Bricker JT, Towbin JA, Abou-Awdi NL, Frazier OH. Mechanical circulatory support in children. Eur J Cardiothorac Surg. 1994; 8: 537-40.


[Seite 63↓]

75. Canter C, Naftel D, Caldwell R, Chinnock R, Pahl E, Frazier E, Kirklin J, Boucek M, Morrow R. Survival and risk factors for death after cardiac transplantation in infants. A multi-institutional study. The Pediatric Heart Transplant Study. Circulation. 1997; 96: 227-31.

76. Rosenthal DN, Dubin AM, Chin C, Falco D, Gamberg P, Bernstein D. Outcome while awaiting heart transplantation in children: a comparison of congenital heart disease and cardiomyopathy. J Heart Lung Transplant. 2000; 19: 751-5.

77. Aronen M, Leijala M, Meri S. Value of C-reactive protein in reflecting the magnitude of complement activation in children undergoing open heart surgery. Intensive Care Med. 1990; 16: 128-32.

78. Meri S, Aronen M, Leijala M. Complement activation during cardiopulmonary bypass in children. Complement. 1988; 5: 46-54.

79. Miyaji K, Hannan RL, Ojito J, Jacobs JP, White JA, Burke RP. Heparin-coated cardiopulmonary bypass circuit: clinical effects in pediatric cardiac surgery. J Card Surg. 2000; 15: 194-8.

80. Chew MS, Brandslund I, Brix-Christensen V, Ravn HB, Hjortdal VE, Pedersen J, Hjortdal K, Hansen OK, Tonnesen E. Tissue injury and the inflammatory response to pediatric cardiac surgery with cardiopulmonary bypass: a descriptive study. Anesthesiology. 2001; 94: 745-53; discussion 5A.

81. Moat NE, Shore DF, Evans TW. Organ dysfunction and cardiopulmonary bypass: the role of complement and complement regulatory proteins. Eur J Cardiothorac Surg. 1993; 7: 563-73.

82. Blume ED, Nelson DP, Gauvreau K, Walsh AZ, Plumb C, Neufeld EJ, Hickey PR, Mayer JE, Newburger JW. Soluble adhesion molecules in infants and children undergoing cardiopulmonary bypass. Circulation. 1997; 96: II-352-7.

83. Jensen E, Bengtsson A, Berggren H, Ekroth R, Andreasson S. Clinical variables and pro-inflammatory activation in paediatric heart surgery. Scand Cardiovasc J. 2001; 35: 201-6.

84. Clarkson Bt, D; horwith, M; Luckey, A. Cyclical edema and shock due to increased capillary permeability. Am J Med. 1960: 193-216.

85. Salat C, Holler E, Schleuning M, Eisele B, Reinhardt B, Kolb H, Pihusch R, Domrath R, Hiller E. Levels of the terminal complement complex, C3a-desArg and C1-inhibitor in adult patients with capillary leak syndrome following bone marrow transplantation. Ann Hematol. 1995; 71: 271-4.


[Seite 64↓]

86. Anderson HL, 3rd, Coran AG, Drongowski RA, Ha HJ, Bartlett RH. Extracellular fluid and total body water changes in neonates undergoing extracorporeal membrane oxygenation. J Pediatr Surg. 1992; 27: 1003-7; discussion 1007-8.

87. Ohta H, Yumara-Yagi K, Sakata N, Inoue M, Kawa-Ha K. Capillary leak syndrome in patients with hemophagocytic lymphohistiocytosis. Acta Paediatr. 1994; 83: 1113-4.

88. Nurnberger W, Heying R, Burdach S, Gobel U. C1 esterase inhibitor concentrate for capillary leakage syndrome following bone marrow transplantation. Ann Hematol. 1997; 75: 95-101.

89. Alexi-Meskishvili V, Weng Y, Uhlemann F, Lange PE, Hetzer R. Prolonged open sternotomy after pediatric open heart operation: experience with 113 patients. Ann Thorac Surg. 1995; 59: 379-83.

90. Brett J, Gerlach H, Nawroth P, Steinberg S, Godman G, Stern D. Tumor necrosis factor/cachectin increases permeability of endothelial cell monolayers by a mechanism involving regulatory G proteins. J Exp Med. 1989; 169: 1977-91.

91. Sonntag J, Emeis M, Vornwald A, Strauss E, Maier RF. Complement activation during plasma production depends on the apheresis technique. Transfus Med. 1998; 8: 205-8.

92. Seghaye MC, Duchateau J, Grabitz RG, Faymonville ML, Messmer BJ, Buro-Rathsmann K, von Bernuth G. Complement activation during cardiopulmonary bypass in infants and children. Relation to postoperative multiple system organ failure. J Thorac Cardiovasc Surg. 1993; 106: 978-87.

93. Nurnberger W, Michelmann I, Petrik K, Holthausen S, Willers R, Lauermann G, Eisele B, Delvos U, Burdach S, Gobel U. Activity of C1 esterase inhibitor in patients with vascular leak syndrome after bone marrow transplantation. Ann Hematol. 1993; 67: 17-21.

94. Graulich J, Sonntag J, Marcinkowski M, Bauer K, Kossel H, Buhrer C, Obladen M, Versmold HT. Complement activation by in vivo neonatal and in vitro extracorporeal membrane oxygenation. Mediators Inflamm. 2002; 11: 69-73.

95. Peek GJ, Firmin RK. The inflammatory and coagulative response to prolonged extracorporeal membrane oxygenation. Asaio J. 1999; 45: 250-63.


[Seite 65↓]

96. Vallhonrat H, Swinford RD, Ingelfinger JR, Williams WW, Ryan DP, Tolkoff-Rubin N, Cosimi AB, Pascual M. Rapid activation of the alternative pathway of complement by extracorporeal membrane oxygenation. Asaio J. 1999; 45: 113-4.

97. Plotz FB, van Oeveren W, Bartlett RH, Wildevuur CR. Blood activation during neonatal extracorporeal life support. J Thorac Cardiovasc Surg. 1993; 105: 823-32.

98. Hirthler M, Simoni J, Dickson M. Elevated levels of endotoxin, oxygen-derived free radicals, and cytokines during extracorporeal membrane oxygenation. J Pediatr Surg. 1992; 27: 1199-202.

99. Westfall SH, Stephens C, Kesler K, Connors RH, Tracy TF, Jr., Weber TR. Complement activation during prolonged extracorporeal membrane oxygenation. Surgery. 1991; 110: 887-91.

100. Hetzer R, Muller JH, Weng Y, Meyer R, Dandel M. Bridging-to-recovery. Ann Thorac Surg. 2001; 71: S109-13; discussion S114-5.

101. Muller J, Wallukat G, Weng YG, Dandel M, Spiegelsberger S, Semrau S, Brandes K, Theodoridis V, Loebe M, Meyer R, Hetzer R. Weaning from mechanical cardiac support in patients with idiopathic dilated cardiomyopathy. Circulation. 1997; 96: 542-9.

102. Seghaye MC, Grabitz RG, Duchateau J, Busse S, Dabritz S, Koch D, Alzen G, Hornchen H, Messmer BJ, Von Bernuth G. Inflammatory reaction and capillary leak syndrome related to cardiopulmonary bypass in neonates undergoing cardiac operations. J Thorac Cardiovasc Surg. 1996; 112: 687-97.

103. Saatvedt K, Lindberg H, Geiran OR, Michelsen S, Aasen AO, Pedersen T, Mollnes TE. Complement activation and release of tumour necrosis factor alpha, interleukin-2, interleukin-6 and soluble tumour necrosis factor and interleukin-2 receptors during and after cardiopulmonary bypass in children. Scand J Clin Lab Invest. 1995; 55: 79-86.

104. Elliott MJ, Finn AH. Interaction between neutrophils and endothelium. Ann Thorac Surg. 1993; 56: 1503-8.

105. Seghaye M, Duchateau J, Bruniaux J, Demontoux S, Bosson C, Serraf A, Lecronier G, Mokhfi E, Planche C. Interleukin-10 release related to cardiopulmonary bypass in infants undergoing cardiac operations. J Thorac Cardiovasc Surg. 1996; 111: 545-53.


[Seite 66↓]

106. Hovels-Gurich HH, Vazquez-Jimenez JF, Silvestri A, Schumacher K, Minkenberg R, Duchateau J, Messmer BJ, von Bernuth G, Seghaye MC. Production of proinflammatory cytokines and myocardial dysfunction after arterial switch operation in neonates with transposition of the great arteries. J Thorac Cardiovasc Surg. 2002; 124: 811-20.

107. Hovels-Gurich HH, Schumacher K, Vazquez-Jimenez JF, Qing M, Huffmeier U, Buding B, Messmer BJ, von Bernuth G, Seghaye MC. Cytokine balance in infants undergoing cardiac operation. Ann Thorac Surg. 2002; 73: 601-8; discussion 608-9.

108. Gerard C. Complement C5a in the sepsis syndrome--too much of a good thing? N Engl J Med. 2003; 348: 167-9.

109. Stieh JH, P; Scheewe, J; Dütschke, P; Kramer, HH. Capillary leak syndrome after open heart surgery for congenital heart defects: therapy with C1-Inhibitor. Biomed Progr. 1996; 9: 13-16.

110. Stiller B, Sonntag J, Dahnert I, Alexi-Meskishvili V, Hetzer R, Fischer T, Lange PE. Capillary leak syndrome in children who undergo cardiopulmonary bypass: clinical outcome in comparison with complement activation and C1 inhibitor. Intensive Care Med. 2001; 27: 193-200.

111. Droder RM, Kyle RA, Greipp PR. Control of systemic capillary leak syndrome with aminophylline and terbutaline. Am J Med. 1992; 92: 523-6.

112. Kang PM, Lawrence C, Khan GA, Hays RM. Fulminating systemic capillary leak syndrome with lymphocytosis and hypogammaglobulinemia. Ren Fail. 1995; 17: 615-7.

113. Seghaye MC, Duchateau J, Grabitz RG, Jablonka K, Wenzl T, Marcus C, Messmer BJ, von Bernuth G. Influence of low-dose aprotinin on the inflammatory reaction due to cardiopulmonary bypass in children. Ann Thorac Surg. 1996; 61: 1205-11.

114. Olsson C, Siegbahn A, Henze A, Nilsson B, Venge P, Joachimsson PO, Thelin S. Heparin-coated cardiopulmonary bypass circuits reduce circulating complement factors and interleukin-6 in paediatric heart surgery. Scand Cardiovasc J. 2000; 34: 33-40.


[Seite 67↓]

115. Borowiec JW, Hagman L, Totterman TH, Pekna M, Venge P, Thelin S. Circulating cytokines and granulocyte-derived enzymes during complex heart surgery. A clinical study with special reference to heparin-coating of cardiopulmonary bypass circuits. Scand J Thorac Cardiovasc Surg. 1995; 29: 167-74.

116. Kagisaki K, Masai T, Kadoba K, Sawa Y, Nomura F, Fukushima N, Ichikawa H, Ohata T, Suzuki K, Taketani S, Matsuda H. Biocompatibility of heparin-coated circuits in pediatric cardiopulmonary bypass. Artif Organs. 1997; 21: 836-40.

117. Olsson C, Siegbahn A, Halden E, Nilsson B, Venge P, Thelin S. No benefit of reduced heparinization in thoracic aortic operation with heparin-coated bypass circuits. Ann Thorac Surg. 2000; 69: 743-9.

118. Steinberg BM, Grossi EA, Schwartz DS, McLoughlin DE, Aguinaga M, Bizekis C, Greenwald J, Flisser A, Spencer FC, Galloway AC, et al. Heparin bonding of bypass circuits reduces cytokine release during cardiopulmonary bypass. Ann Thorac Surg. 1995; 60: 525-9.

119. Bando K, Turrentine MW, Vijay P, Sharp TG, Sekine Y, Lalone BJ, Szekely L, Brown JW. Effect of modified ultrafiltration in high-risk patients undergoing operations for congenital heart disease. Ann Thorac Surg. 1998; 66: 821-7; discussion 828.

120. Maluf MA, Mangia C, Silva C, Carvalho WB, Carvalho AC, Buffolo E. Conventional and conventional plus modified ultrafiltration during cardiac surgery in high-risk congenital heart disease. J Cardiovasc Surg (Torino). 2001; 42: 465-73.

121. Watanabe T, Sakai Y, Mayumi T, Shimomura T, Song MH, Tajima K, Suenaga Y, Kawaradani Y, Saito Y, Yamada T. Effect of ultrafiltration during cardiopulmonary bypass for pediatric cardiac surgery. Artif Organs. 1998; 22: 1052-5.

122. Thompson LD, McElhinney DB, Findlay P, Miller-Hance W, Chen MJ, Minami M, Petrossian E, Parry AJ, Reddy VM, Hanley FL. A prospective randomized study comparing volume-standardized modified and conventional ultrafiltration in pediatric cardiac surgery. J Thorac Cardiovasc Surg. 2001; 122: 220-8.

123. Bronicki RA, Backer CL, Baden HP, Mavroudis C, Crawford SE, Green TP. Dexamethasone reduces the inflammatory response to cardiopulmonary bypass in children. Ann Thorac Surg. 2000; 69: 1490-5.


[Seite 68↓]

124. Seghaye MC, Duchateau J, Grabitz RG, Wolff T, Marcus C, Engelhardt W, Hörnchen H, Messmer BJ, von Bernuth G. Effect of sodium nitroprusside on complement activation induced by cardiopulmonary bypass: a clinical and experimental study. J Thorac Cardiovasc Surg. 1996; 111: 882-92.

125. Yeh T, Jr., Parmar JM, Rebeyka IM, Lofland GK, Allen EL, Dignan RJ, Dyke CM, Wechsler AS. Limiting edema in neonatal cardiopulmonary bypass with narrow-range molecular weight hydroxyethyl starch. J Thorac Cardiovasc Surg. 1992; 104: 659-65.

126. Sonntag J, Stiller B, Walka MM, Maier RF. Anaphylatoxins in fresh-frozen plasma. Transfusion. 1997; 37: 798-803.

127. Caliezi C, Wuillemin WA, Zeerleder S, Redondo M, Eisele B, Hack CE. C1-Esterase inhibitor: an anti-inflammatory agent and its potential use in the treatment of diseases other than hereditary angioedema. Pharmacol Rev. 2000; 52: 91-112.

128. Waytes AT, Rosen FS, Frank MM. Treatment of hereditary angioedema with a vapor-heated C1 inhibitor concentrate. N Engl J Med. 1996; 334: 1630-4.

129. Nurnberger W, Gobel U, Stannigel H, Eisele B, Janssen A, Delvos U. C1-inhibitor concentrate for sepsis-related capillary leak syndrome. Lancet. 1992; 339: 990.

130. Hack CE, de Zwaan C, Hermens WT. Safety of C1-inhibitor for clinical use. Circulation. 2002; 106: e132; author reply e132.

131. Tassani P, Kunkel R, Richter JA, Oechsler H, Lorenz HP, Braun SL, Eising GP, Haas F, Paek SU, Bauernschmitt R, Jochum M, Lange R. Effect of C1-esterase-inhibitor on capillary leak and inflammatory response syndrome during arterial switch operations in neonates. J Cardiothorac Vasc Anesth. 2001; 15: 469-73.

132. Poole-Wilson PA. Innovative treatments for myocardial infarction; design, purpose and consequences of early studies. Eur Heart J. 2002; 23: 1640-2.

133. Akita N, Nakase H, Kaido T, Kanemoto Y, Sakaki T. Protective effect of c1 esterase inhibitor on reperfusion injury in the rat middle cerebral artery occlusion model. Neurosurgery. 2003; 52: 395-401.

134. Schousboe I. Binding of activated Factor XII to endothelial cells affects its inactivation by the C1-esterase inhibitor. Eur J Biochem. 2003; 270: 111-8.


[Seite 69↓]

135. Nielsen EW, Mollnes TE, Harlan JM, Winn RK. C1-inhibitor reduces the ischaemia-reperfusion injury of skeletal muscles in mice after aortic cross-clamping. Scand J Immunol. 2002; 56: 588-92.

136. Wozniak G, Noll T, Akinturk H, Thul J, Muller M. Factor XIII prevents development of myocardial edema in children undergoing surgery for congenital heart disease. Ann N Y Acad Sci. 2001; 936: 617-20.

137. Noll T, Wozniak G, McCarson K, Hajimohammad A, Metzner HJ, Inserte J, Kummer W, Hehrlein FW, Piper HM. Effect of factor XIII on endothelial barrier function. J Exp Med. 1999; 189: 1373-82.

138. Drews T, Loebe M, Jurmann M, zu Dohna R, Erben M, Hetzer R. Outpatients on biventricular assist devices. Thorac Cardiovasc Surg. 2001; 49: 296-9.

139. Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, Long JW, Ascheim DD, Tierney AR, Levitan RG, Watson JT, Meier P, Ronan NS, Shapiro PA, Lazar RM, Miller LW, Gupta L, Frazier OH, Desvigne-Nickens P, Oz MC, Poirier VL. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med. 2001; 345: 1435-43.

140. Loebe M, Gorman K, Burger R, Gage JE, Harke C, Hetzer R. Complement activation in patients undergoing mechanical circulatory support. Asaio J. 1998; 44: M340-6.

141. Seib PM, Faulkner SC, Erickson CC, Van Devanter SH, Harrell JE, Fasules JW, Frazier EA, Morrow WR. Blade and balloon atrial septostomy for left heart decompression in patients with severe ventricular dysfunction on extracorporeal membrane oxygenation. Catheter Cardiovasc Interv. 1999; 46: 179-86.

142. Booth KL, Roth SJ, Perry SB, del Nido PJ, Wessel DL, Laussen PC. Cardiac catheterization of patients supported by extracorporeal membrane oxygenation. J Am Coll Cardiol. 2002; 40: 1681-6.

143. Nakano T, Tominaga R, Morita S, Masuda M, Nagano I, Imasaka K, Yasui H. Impacts of pulsatile systemic circulation on endothelium-derived nitric oxide release in anesthetized dogs. Ann Thorac Surg. 2001; 72: 156-62.

144. Loebe M, Koster A, Sanger S, Potapov EV, Kuppe H, Noon GP, Hetzer R. Inflammatory response after implantation of a left ventricular assist device: comparison between the axial flow MicroMed DeBakey VAD and the pulsatile Novacor device. Asaio J. 2001; 47: 272-4.


[Seite 70↓]

145. Margulies KB. Reversal mechanisms of left ventricular remodeling: Lessons from left ventricular assist device experiments. J Card Fail. 2002; 8: S500-5.

146. Razeghi P, Young ME, Ying J, Depre C, Uray IP, Kolesar J, Shipley GL, Moravec CS, Davies PJ, Frazier OH, Taegtmeyer H. Downregulation of metabolic gene expression in failing human heart before and after mechanical unloading. Cardiology. 2002; 97: 203-9.

147. Helman DN, Maybaum SW, Morales DL, Williams MR, Beniaminovitz A, Edwards NM, Mancini DM, Oz MC. Recurrent remodeling after ventricular assistance: is long-term myocardial recovery attainable? Ann Thorac Surg. 2000; 70: 1255-8.

148. Frazier OH, Benedict CR, Radovancevic B, Bick RJ, Capek P, Springer WE, Macris MP, Delgado R, Buja LM. Improved left ventricular function after chronic left ventricular unloading. Ann Thorac Surg. 1996; 62: 675-81; discussion 681-2.

149. Hetzer R, Loebe M, Weng Y, Alexi-Meskhishvili V, Stiller B. Pulsatile pediatric ventricular assist devices: Current results for bridge to transplantation. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 1999; 2: 157-176.


[Seite 71↓]

ZUSAMMENSTELLUNG AUSGEWÄHLTER PUBLIKATIONEN

Sonntag J, Dähnert I, Stiller B, Hetzer R, Lange PE. Complement and contact activation during cardiovascular operations in infants. Ann Thorac Surg 1998;65:525-31

Stiller B, Sonntag J, Dähnert I, Alexi-Meskishvili V, Hetzer R, Fischer T, Lange PE.

Capillary leak syndrome in children who undergo cardiopulmonary bypass:

Clinical outcome in comparison with complement activation and C1-Inhibitor.

Intensive Care Med 2001;27:193-200.

Hetzer R, Loebe M, Potapov EV, Weng Y, Stiller B, Hennig E, Alexi-Meskishvili V, Lange PE. Circulatory support with pneumatic paracorporeal ventricular assist device in infants and children. Ann Thorac Surg 1998; 66:1498-506.

Stiller B, Hetzer R, Weng Y, Hummel M, Hennig E, Nagdyman N, Ewert P, Lehmkuhl H, Lange PE. Heart transplantation in children following mechanical circulatory support with pulsatile pneumatic assist device. J Heart Lung Transplant –in press 2003

Stiller B, Dähnert I, Weng YG, Hennig E, Hetzer R, Lange PE. Children may survive severe myocarditis with prolonged use of biventricular assist devices. Heart 1999;82:237-240.

Stiller B, Dähnert I, Berger F, Weng Y, Loebe M, Alexi-Meskhishvili V, Hetzer R,

Lange PE. Kunstherzeinsatz im Terminalstadium der dilatativen Kardio­myopathie

im Kindesalter. Z Kardiol 2000;89:1039-1045.


[Seite 72↓]


© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.
DiML DTD Version 3.0Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML-Version erstellt am:
29.04.2004